Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Insiders Buy Stock at Bank of America and Ligand Pharmaceuticals

By

Plus, sales at Mastercard, Pacira Pharmaceuticals, and Boulder Brands.

PrintPRINT
In a victory for common sense, the trading behavior of company executives, directors, and large shareholders in the stocks of firms they're registered "insiders" at have been proven profitable to monitor by both academic studies and (more importantly) the experience of your fellow professional investors.

Below are lists of the top 10 mainly open-market insider purchases and sales filed at the Securities and Exchange Commission Friday, January 25, 2013 as ranked by dollar value.

Please note, however, that these are factual lists, not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

In purchases, the private investment firm BVF Partners, a beneficial owner of biotechnology company Ligand Pharmaceuticals (NASDAQ:LGND), bought $783,181 worth of company stock. David Yost, a Director of Bank of America (NYSE:BAC) since August 2012, bought $230,600 worth of company stock. At bank holding company Kentucky Bancshares (PINK:KTYB), Director Buckner Woodford IV bought $43,480 worth of company stock. Additionally, Vice President James Elliott bought $19,750, and President and CEO Louis Prichard bought $14,283 worth of company stock. Wendy Beck, Vice President and Chief Financial Officer of Norwegian Cruise Line (NASDAQ:NCLH), bought $22,800 worth of company stock.

In sales, the MasterCard Foundation, a private, independent foundation devoted to microfinance in developing countries, as well as beneficiary owner of MasterCard (NYSE:MA), sold $18,493,454 worth of company stock. Sanderling Ventures Partners, an investment firm dedicated to building new biomedical companies and beneficial owner of Pacira Pharmaceuticals (NASDAQ:PCRX), sold $9,465,000 worth of company stock. The money management firm Adage Capital, a beneficial owner of Boulder Brands (NASDAQ:BDBD), sold $2,985,435 worth of company stock. The company, formerly known as Smart Balance before it officially changed its name earlier this month, is the fourth largest marketer of natural foods. At IBM (NYSE:IBM), Vice President Robert Weber sold $1,473,460 worth of company stock.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
BO
B
$783,181
2
DIR
B
$230,600
3
BO
B
$102,345
4
BO
B
$51,396
5
DIR
B
$43,480
6
DIR
B
$24,480
7
VP,CFO
JB*
$22,800
8
VP
B
$19,750
9
PR,CEO,DIR
B
$14,283
10
CB,DIR,BO
B
$10,000

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
BO
S
$18,493,454
2
BO
JS*
$9,465,000
3
BO
S
$2,985,435
4
DIR
AS
$2,941,266
5
BO
S
$2,524,145
6
VCB,VP,DIR
AS
$2,368,634
7
PR
S
$2,149,506
8
CB,CEO,BO
AS
$1,675,959
9
VP
S
$1,473,460
10
VP
S
$1,208,244

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

Editor's note: Jonathan Moreland is the founder of Insider Insights and author of "Profit From Legal Insider Trading."
No positions in stocks mentioned.
PrintPRINT

Busy? Subscribe to our free newsletter!

Submit
 

WHAT'S POPULAR IN THE VILLE